Characterization of a novel gadolinium-based high molecular weight polymer as an intravascular MR contrast agent

@inproceedings{Kirchherr2011CharacterizationOA,
  title={Characterization of a novel gadolinium-based high molecular weight polymer as an intravascular MR contrast agent},
  author={Anne Kirchherr and Danielle Franke and Detlef Stiller and Andreas Briel},
  year={2011}
}
Objectives: Blood pool contrast agents used in magnetic resonance imaging (MRI) are characterized by intravascular distribution and prolonged persistence in the blood compared with conventional contrast agents in clinical use such as Gd-DTPA (Magnevist, Bayer Pharma AG, Germany) and Gd-DOTA (Dotarem, Guerbet, France). Since the size of the contrast agent… CONTINUE READING